ArticleFuture oncology (London, England)2022
Plain language summary of NRG1 fusions in cancer: current knowledge and treatment with afatinib and other drugs.
Stephen V LiuPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it